These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33685990)
1. Combined Inhibition of p38MAPK and PIKfyve Synergistically Disrupts Autophagy to Selectively Target Cancer Cells. O'Connell CE; Vassilev A Cancer Res; 2021 Jun; 81(11):2903-2917. PubMed ID: 33685990 [TBL] [Abstract][Full Text] [Related]
2. Selective elimination of pluripotent stem cells by PIKfyve specific inhibitors. Chakraborty AR; Vassilev A; Jaiswal SK; O'Connell CE; Ahrens JF; Mallon BS; Pera MF; DePamphilis ML Stem Cell Reports; 2022 Feb; 17(2):397-412. PubMed ID: 35063131 [TBL] [Abstract][Full Text] [Related]
3. A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis. Sharma G; Guardia CM; Roy A; Vassilev A; Saric A; Griner LN; Marugan J; Ferrer M; Bonifacino JS; DePamphilis ML Autophagy; 2019 Oct; 15(10):1694-1718. PubMed ID: 30806145 [TBL] [Abstract][Full Text] [Related]
4. PIKFYVE inhibitors trigger interleukin-24-dependent cell death of autophagy-dependent melanoma. Roy A; Chakraborty AR; DePamphilis ML Mol Oncol; 2024 Apr; 18(4):988-1011. PubMed ID: 38414326 [TBL] [Abstract][Full Text] [Related]
5. Akebia saponin E, as a novel PIKfyve inhibitor, induces lysosome-associated cytoplasmic vacuolation to inhibit proliferation of hepatocellular carcinoma cells. Peng P; Jia D; Cao L; Lu W; Liu X; Liang C; Pan Z; Fang Z J Ethnopharmacol; 2021 Feb; 266():113446. PubMed ID: 33031902 [TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of human endometrial carcinoma cells with different PTEN expression to mitogen-activated protein kinase signaling inhibits and implications for therapy. Xiao L; Yang YB; Li XM; Xu CF; Li T; Wang XY J Cancer Res Clin Oncol; 2010 Jul; 136(7):1089-99. PubMed ID: 20087603 [TBL] [Abstract][Full Text] [Related]
7. p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment. Marengo B; De Ciucis CG; Ricciarelli R; Furfaro AL; Colla R; Canepa E; Traverso N; Marinari UM; Pronzato MA; Domenicotti C Cell Death Dis; 2013 Apr; 4(4):e589. PubMed ID: 23579276 [TBL] [Abstract][Full Text] [Related]
8. Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models. Chiacchiera F; Grossi V; Cappellari M; Peserico A; Simonatto M; Germani A; Russo S; Moyer MP; Resta N; Murzilli S; Simone C Cancer Lett; 2012 Nov; 324(1):98-108. PubMed ID: 22579651 [TBL] [Abstract][Full Text] [Related]
9. P38 MAP kinase functions as a switch in MS-275-induced reactive oxygen species-dependent autophagy and apoptosis in human colon cancer cells. Zhan Y; Gong K; Chen C; Wang H; Li W Free Radic Biol Med; 2012 Aug; 53(3):532-43. PubMed ID: 22634147 [TBL] [Abstract][Full Text] [Related]
10. Activation of p38MAPK signaling cascade in a VSMC injury model: role of p38MAPK inhibitors in limiting VSMC proliferation. Jacob T; Ascher E; Alapat D; Olevskaia Y; Hingorani A Eur J Vasc Endovasc Surg; 2005 May; 29(5):470-8. PubMed ID: 15966085 [TBL] [Abstract][Full Text] [Related]
11. Cotargeting BET proteins overcomes resistance arising from PI3K/mTOR blockade-induced protumorigenic senescence in colorectal cancer. Lee HS; Lee S; Cho KH Int J Cancer; 2020 Nov; 147(10):2824-2837. PubMed ID: 32599680 [TBL] [Abstract][Full Text] [Related]
12. Aldosterone induces apoptosis in rat podocytes: role of PI3-K/Akt and p38MAPK signaling pathways. Chen C; Liang W; Jia J; van Goor H; Singhal PC; Ding G Nephron Exp Nephrol; 2009; 113(1):e26-34. PubMed ID: 19590239 [TBL] [Abstract][Full Text] [Related]
13. p38 inhibitor inhibits the apoptosis of cowanin-treated human colorectal adenocarcinoma cells. Chowchaikong N; Nilwarangkoon S; Laphookhieo S; Tanunyutthawongse C; Watanapokasin R Int J Oncol; 2018 Jun; 52(6):2031-2040. PubMed ID: 29620273 [TBL] [Abstract][Full Text] [Related]
14. Targeting cap-dependent translation to inhibit Chikungunya virus replication: selectivity of p38 MAPK inhibitors to virus-infected cells due to autophagy-mediated down regulation of phospho-ERK. Mudaliar P; Pradeep P; Abraham R; Sreekumar E J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34328830 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells. Kim KY; Park KI; Kim SH; Yu SN; Park SG; Kim YW; Seo YK; Ma JY; Ahn SC Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524116 [TBL] [Abstract][Full Text] [Related]
16. p38MAPK inhibitor SB203580 sensitizes human SNU-C4 colon cancer cells to exisulind-induced apoptosis. Lim SJ; Lee YJ; Lee E Oncol Rep; 2006 Nov; 16(5):1131-5. PubMed ID: 17016604 [TBL] [Abstract][Full Text] [Related]
17. Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control. Wible DJ; Parikh Z; Cho EJ; Chen MD; Jeter CR; Mukhopadhyay S; Dalby KN; Varadarajan S; Bratton SB Cell Death Dis; 2024 Jan; 15(1):80. PubMed ID: 38253602 [TBL] [Abstract][Full Text] [Related]
18. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. Kim JY; Choi JA; Kim TH; Yoo YD; Kim JI; Lee YJ; Yoo SY; Cho CK; Lee YS; Lee SJ J Cell Physiol; 2002 Jan; 190(1):29-37. PubMed ID: 11807808 [TBL] [Abstract][Full Text] [Related]
19. Intermittent inhibition of FYVE finger-containing phosphoinositide kinase induces melanosome degradation in B16F10 melanoma cells. Kawaguchi K; Watanabe M; Furukawa S; Koga K; Kanamori H; Ikemoto MJ; Takashima S; Maeda M; Oh-Hashi K; Hirata Y; Furuta K; Takemori H Mol Biol Rep; 2023 Jul; 50(7):5917-5930. PubMed ID: 37248430 [TBL] [Abstract][Full Text] [Related]
20. Combined Menin and EGFR Inhibitors Synergize to Suppress Colorectal Cancer via EGFR-Independent and Calcium-Mediated Repression of SKP2 Transcription. Katona BW; Glynn RA; Paulosky KE; Feng Z; Davis CI; Ma J; Berry CT; Szigety KM; Matkar S; Liu Y; Wang H; Wu Y; He X; Freedman BD; Brady DC; Hua X Cancer Res; 2019 May; 79(9):2195-2207. PubMed ID: 30877106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]